3 December 2021 in British Journal of Dermatology
1 January 2017 in Pharmacognosy Research
Background: Endometrial cancer (EC) is the most common gynecologic malignancy in developed countries. Annonacin, a natural pure compound extracted from the seeds of Annona muricata, is a potential alternative therapeutic agent to treat EC. Objective: To study the antitumor activity of annonacin and its mechanism of action in EC cells (ECCs). Materials and Methods: Viability of ECCs treated with annonacin for 72 h was determined using methyl thiazolyl tetrazolium assay. The induction of cell cycle arrest and apoptotic cell death was evaluated using propidium iodide and annexin V-PE/7-AAD assay, respectively. DNA strand breaks were visualized using transferase dUTP nick end labeling assay, and the effects of annonacin on survival signaling were determined using western blotting. Results: Annonacin exhibited antiproliferative effects on EC cell lines (ECC-1 and HEC-1A) and primary cells (EC6-ept and EC14-ept) with EC50values ranging from 4.62 to 4.92 μg/ml. EC cells were shown arrested at G2/M phase after treated with 4 μg/ml of annonacin for 72 h. This led to a significant increase in apoptotic cell death (65.7%) in these cells when compared to vehicle-treated cells (P < 0.005). We further showed that annonacin-mediated apoptotic cell death was associated with an increase in caspase-3 cleavage and DNA fragmentation. Cell apoptosis was accompanied with downregulation of extracellular signal-regulated kinase survival protein expression and induction of G2/M cell cycle arrest. Conclusion: Annonacin may be a potential novel therapeutic agent for EC patients. Abbreviations Used: 7-AAD: 7-Amino-Actinomycin, ATP: Adenosine diphosphate, BSA: Bovine serum albumin, DNA: Deoxyribonucleic acid, EC: Endometrial cancer, ECC-1: Endometrial cancer cell-1, EC50: Half maximal effective concentration, Ept: Epithelial, FBS: Fetal bovine serum, HEC-1A: Human endometrial carcinoma-1A, MTT: Methyl thiazolyl tetrazolium, NaCl: Sodium chloride, NADH: Nicotinamide adenine dinucleotide, RPMI 1640: Roswell Park Memorial Institute Medium, SDS: Sodium dodecyl sulfate
24 September 2026 in BJOG: An International Journal of Obstetrics & Gynaecology
Objective: To demonstrate the presence of peritoneal fluid (PF)‐derived small extracellular vesicles (sEVs) in endometriosis and control samples, to characterise their protein content and to define endometriosis‐specific biomarkers within the sEV proteome. Design: Case–control experimental study. Setting: Academic endometriosis centre. Sample: PF samples from women between 18 and 49 years old ( n = 63). Methods: sEVs were enriched using size exclusion chromatography (SEC), and characterised by nanoparticle tracking analysis (NTA), immunoblotting and mass spectrometry, according to surgically‐defined disease stage and cycle phase (control, rASRM stages I–II and III–IV endometriosis, in proliferative, secretory, and menstrual phases). FragPipe was used for protein identification. Main Outcome Measures: Protein content of sEVs from control and endometriosis PF samples. Results: sEVs were identified in PF of women by NTA, immunoblotting and mass spectrometry. Four proteins were significantly different across all samples: fructose‐bisphosphate aldolase A (ALDOA: 3.12‐fold increase in control samples, p = 0.0164), heat shock protein 90‐alpha (HSP90AA1: 2.14‐fold increase in control samples, p = 0.0245), collagen alpha‐1 (XV) chain (COL15A1: 1.83‐fold increase in control samples, p = 0.0421), and protein S100‐A10 (2.54‐fold increase in endometriosis samples, p = 0.0421). Conclusions: PF‐derived sEVs differ between endometriosis and control patients. Concentrations vary regardless of cycle phase and disease stage, and this difference appears to be reflected in the proteomics analysis. However, higher sampling numbers are needed to confirm findings and functional assays to be performed delineate sEV function in endometriosis pathophysiology. Correlating PF‐derived sEV proteins with those in blood or urine could help further understand endometriosis and lead to the identification of biomarkers for diagnosis.